YSYe. T. Soloviova

Ye. T. Soloviova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ye. T. Soloviova has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The use of memantine for the correction of cognitive impairment in people who have suffered ischemic stroke: results of clinical observation and literature review

    by N.O Nekrasova, А.н Militovska, I.I Chernenko, Y.T Solovіova, I.V Darii

    Background. Post-stroke cognitive impairment is a common complication of ischemic stroke with an unfavorable long-term prognosis associated with decreased functional independence and an increased risk of recurrent vascular events. Despite the established role of glutamate-mediated excitotoxicity in the formation of cognitive deficits in ischemic stroke, clinical data on the use of NMDA receptor antagonists directly in the post-stroke population remain limited. Purpose – to assess the dynamics of cognitive and functional status in patients with post-stroke cognitive impairment during 9 months of memantine therapy, as well as to conduct a critical analysis of the current literature on the pathogenesis of post-stroke cognitive impairment and clinical data on the use of memantine in vascular cognitive pathology. Materials and methods. The clinical part included 60 patients with cognitive impairment after stroke (MMSE ≤ 25 points): the main group received memantine (titration 5→20 mg/day) as part of standard therapy (n = 30), the control group received only standard therapy (n = 30). The duration of observation was 9 months; control points: 0, 3, 6, 9 months. Statistical analysis: Shapiro–Wilk test, Wilcoxon test for dependent samples, Mann–Whitney test, Cohen’s coefficient (p < 0.05). A narrative review of the literature was conducted using the MEDLINE/PubMed and Scopus databases (2021–2026; keywords: cognitive impairment after stroke, memantine, NMDA receptor, vascular cognitive impairment). Results. The groups were comparable in terms of baseline characteristics (p > 0.05). In the main group, statistically significant positive dynamics of MMSE were found at all control points: at the 9th month Δ = +2.7 points (p = 0.001; Cohen’s d = 0.74). The dynamics of the Barthel index were also significant with an increasing effect: at the 9th month Δ = +10.8 points (p < 0.001; Cohen’s d = 0.97). In the control group, statistically significant changes in MMSE and Barthel index were not recorded (p = 0.087–0.143). Between-group differences at the 9th month: MMSE +1.1 points (p = 0.041), Barthel +6.1 points (p = 0.028). Subgroup analysis revealed a statistically significant improvement in patients with mild and moderate cognitive impairment (MCI); in the severe PD subgroup, the effect did not reach statistical significance (p > 0.05). Conclusions. The addition of memantine to standard therapy was associated with modest improvements in cognitive and functional status at 9 months of follow-up, mainly in patients with mild to moderate cognitive impairment. The results obtained in our study need to be confirmed in larger randomized trials.

  • Parkinson's disease in clinical practice: from onset to surgical treatment (clinical case)

    by N. O. Nekrasova, V. S. Sova, Ye. T. Soloviova, L. V. Tykhonova

    Background. Parkinsonʼs disease is one of the most common progressive neurodegen-erative disorders of the central nervous system and poses a significant medical and social challenge due to its steadily increasing prevalence, the resulting disability among patients, and a substantial decline in quality of life. Despite significant progress in understanding the pathogenesis of the disease and the development of international clinical guidelines, cur-rent treatments remain predominantly symptomatic and are unable to modify the course of the disease. Early diagnosis of Parkinsonʼs disease poses a particular challenge, given the prolonged prodromal period, clinical heterogeneity, and the predominance of non-motor symptoms in the early stages. In Ukraine, additional factors that heighten the urgency of the problem include uneven access to specialized care, a limited number of physicians specializing in movement disorders, and the impact of chronic psychoemotional stress associated with wartime events, which may contribute to earlier clinical manifestation and faster disease progression. Problem statement. Despite the rapid advances in neuroscience in the 21st century, Parkinsonʼs disease remains challenging to diagnose in a timely manner and manage effectively. The difficulties in clinical assessment stem not only from the variability of motor symptoms but also from the high prevalence of non-motor symptoms, including depression, anxiety disorders, sleep disturbances, autonomic dysfunction, and cognitive impairments, which often mask the early stages of the disease. In Ukraine, the problem is compounded by the lack of a standardized, practical care pathway for patients with Parkinsonʼs disease, leading to the use of outdated or suboptimal therapeutic strategies, delays in treatment escalation, and late referral for neurosurgical interventions, particularly deep brain stimulation. Purpose – to analyze the clinical course of Parkinsonʼs disease using the case of a single patient-from the onset of the disease to the stage of functional neurosurgical treatment-to evaluate the effectiveness and limitations of the therapeutic approaches used, and to compare the findings with current international clinical guidelines and scientific literature. Materials and methods. An analysis was conducted of the current scientific literature and international clinical guidelines regarding the diagnosis and treatment of Parkinsonʼs disease. The medical records of a patient with a long-term course of the disease were reviewed in detail, including data from clinical examinations, neuroimaging studies, and medical and surgical therapy. The clinical case was evaluated in accordance with the diagnostic criteria of the Movement Disorder Society (MDS) and the principles of evi-dence-based medicine. Conclusions. The clinical case presented here demonstrates that the key factors compli-cating the management of patients with Parkinsonʼs disease include delayed presentation for medical care, insufficient attention to prodromal and non-motor symptoms, and the fail-ure to adjust the treatment strategy in a timely manner in accordance with current guide-lines. The use of outdated approaches in the early stages of the disease and unsystematic monitoring of disease progression may contribute to faster progression and early disability in patients. At the same time, experience with functional neurosurgical methods, particu-larly deep brain stimulation, confirms their effectiveness in patients with medication-resis-tant motor fluctuations, provided there is proper patient selection and timely referral. The results obtained underscore the need to implement a standardized patient pathway for Parkinsonʼs disease in Ukraine, to raise physiciansʼ awareness of current diagnostic criteria and therapeutic options, and to develop a multidisciplinary approach to the man-agement of this patient population.

  • Relevant problems of differential diagnostics of myelitis (by a clinical example)

    by Yе.T. Solovyova, N.O. Nekrasova, A.V. Stromylo, А.н. Militovska, O.I. Kauk

    Background. Infammation of the central nervous system (CNS) takes a special place among all the neurological diseases. Myelitis serves an example of such an infammation, remaining in the spotlight of scientifc research. First, as locally isolated form of lesion, it occurs fairly rarely, therefore the obstacles in systematizing the data about its etiology, pathogenesis, classifcation, clinical features, etc. Second, making the fnal diagnosis may be challenging, since there are many autoimmune, demyelinating, and other diseases, which could result into the spinal cord infam mation. Moreover, the rational way of examining such patients is also unclear – the question is whether itʼs realistic to fnd out the exact reason of myelitis in every single case, or itʼs acceptable to postulate «idiopathic» forms. Altogether, after taking into consideration the presence of controversial information, it would be reasonable to perform a literature review and to present a clinical case in this article. Purpose – the purpose of this work is to compile the relevant data about trans verse myelitis and illustrate it with a clinical example. Materials and Methods. The literature resources dedicated to transverse myelitis and the patientʼs medical documentation were analyzed. Results. The patientʼs anamnesis and the results of his laboratory and instrumental tests indicated the presence of transverse myelitis, accompanied with paraplegia,hypoesthesia beneath the Th8-9 level, and the central type of pelvic organ dysfunction. Anti-infammatory and immunoglobulin therapy resulted in a positive outcome:partial recovery of motor function in the lower limbs (up to 2–3 points on the MRC scale), decreased sensory defcit, and partial restoration of bladder control. Conclusions. Transverse myelitis as an isolated form of the CNS lesion is a challenge for neurological practice. The main difculties are associated with the necessity of making the diagnosis by method of exclusion, implying performing numerous high-priced tests which may not justify the means wasted on diagnostics. The future of such patients is also indefnite. According to the most pessimistic assessments, up to two third of cases remain without an identifed reason of myelitis, and up to one third of the examinees have severe neurological defcit after this disease, resulting into permanent disability. In this case the outcome was a favorable recovery trend was observed: partial motor improvement, reduced sensory impairment, and better bladder control.

  • Open Access

    A clinical case of secondary erythromelalgia

    by Yе.T. Solovyova, N.O. Nekrasova, A.V. Stromylo, Є.т. Соловйова

    Background. Angiotrophoneuroses treatment is supposed to be one of the most sophisticated tasks for neurologists. This is the group of diseases, characterized by impairment of vascular tone regulation. The particular example of angiotrophoneuroses is erythromelalgia (also known as Mitchell syndrome), which results into neuropathic pain, autonomic dysfunction, and dystrophic changes in tissues, therefore poor level of life quality of patients with this condition. Unfortunately, comprehensive understanding of its pathophysiology is missing in view of the fact that itʼs rare and can be masked at the background of other myeloproliferative, demyelinating, metabolic, autoimmune and other diseases. Performing analysis of the clinical case of the secondary form of erythromelalgia gives an opportunity to attract attention of many healthcare specialists, such as neurologists, dermatologists, haematologists, vascular surgeons, etc. It is exceptionally important to highlight this topic, because patients with Mitchell syndrome can search for help visiting the doctors of different specialties. Purpose – to describe the clinical case of erythromelalgia, occurred in the patient with erythremia. Materials and Methods. The results of an objective neurological examination, the DN4 neuropathic pain diagnostic questionnaire and the TSS (Total Symptoms Score) assessment, as well as the reporting of laboratory and instrumental diagnostic examinations of a patient with Mitchellʼs syndrome, were used. Results. Neurological examination and paraclinical tests implied the patient had erythromelalgia, polyneuropathy (with vegetative-trophic and sensitive disorders, as well as movement disorders in the limbs, mainly in the distal parts), and erythremia. The use of complex therapy (gabapentin, L-lysine escinate, keltican, propranolol, suprastin, alerzin, methotrexate, acetylsalicylic acid) made it possible to improve the patientʼs condition. Conclusions. Erythromelalgia is a severe disease with high resistance to existent pharmacological approaches and unfavorable outcome. Although the modern drugs make it possible to reduce the subjective severity of symptoms, the frequency of paroxysms is hard to be controlled. Therefore, there is an urgent need to find new therapeutic approaches to the treatment of Mitchellʼs disease and the development of new methods that allow the detection of secondary forms of erythromelalgia.


  • Open Access

    Clinical case of demyelynating polyneuropathy of patient with autoimmune polyendocrine syndrome

    by Ye.T. Solovyova, N.O. Nekrasova, A.V. Stromylo, L.V. Tykhonova, Є.т. Соловйова

    Background. The function of a nervous system (NS) has a strong correlation with a somatic state of each individual. Therefore, somatoneurology as a new branch of medicine appeared. Nowadays due to pathophysiological researches we possess the knowledge of mechanisms on NS damage at the background of diseases of endocrine, cardiovascular, digestive, respiratory and other systems. Nevertheless, practically all these processes are difficult to be separated in each case of illness because of the complexity of their simultaneous interaction and polymorphism of clinical symptoms. Autoimmune diseases are worth special attention due to their chameleon-like way of progressing when different organ systems get involved with new exacerbations. Moreover, the pathogenesis of NS damage at the background of autoimmunisation is not only connected with the response of nervous tissue on inflammation and demyelination, but it’s also a result of multiorgan disfunction – a consequence of their autoimmune disruption. According to the mentioned fact the clinical case of autoimmune polyendocrine syndrome described in this article is very representative because of the presence of combination of immune system dysfunction (what is a potential trigger of demyelination) and the impact of glucose toxicity phenomenon on NS (a symptom of diabetes mellitus caused by autoimmune pancreatitis). To sum up with, studying somatoneurological features of autoimmune diseases is a relevant topic for practitioners at the «century of autoimmune diseases». Purpose – to describe the clinical case of polyneuropathy at the background of autoimmune polyendocrine syndrome. Materials and Methods. The results of objective examination and data of instrumental and laboratory tests protocols made at «Kharkiv Regional Clinical Hospital» were used. Results. Polyneuropathic type of nervous system damage was verified due to electroneuromyographic examination and the scale «Neuropathy Impairment Score of Lower Limbs» (NIS-LL). The efficiency of combined therapy with «Nerviplex», «Dialipon» and «Gabapentin» was demonstrated in this case. Conclusions. Autoimmune diseases can lead to nervous tissue damage due to different pathophysiological mechanisms, including the direct impact on it with the processes of inflammation and demyelination but also as a secondary consequence of multiorgan dysfunction at the background of immune autoagression.